CN114573617A - Ternary electrolyte containing saturated heterocycles, and preparation and application thereof - Google Patents

Ternary electrolyte containing saturated heterocycles, and preparation and application thereof Download PDF

Info

Publication number
CN114573617A
CN114573617A CN202011380889.2A CN202011380889A CN114573617A CN 114573617 A CN114573617 A CN 114573617A CN 202011380889 A CN202011380889 A CN 202011380889A CN 114573617 A CN114573617 A CN 114573617A
Authority
CN
China
Prior art keywords
group
ring
electrolyte
battery
membered ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN202011380889.2A
Other languages
Chinese (zh)
Inventor
俞会根
杨萌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing WeLion New Energy Technology Co ltd
Original Assignee
Beijing WeLion New Energy Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing WeLion New Energy Technology Co ltd filed Critical Beijing WeLion New Energy Technology Co ltd
Priority to CN202011380889.2A priority Critical patent/CN114573617A/en
Publication of CN114573617A publication Critical patent/CN114573617A/en
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/022Boron compounds without C-boron linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0816Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring comprising Si as a ring atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/0825Preparations of compounds not comprising Si-Si or Si-cyano linkages
    • C07F7/083Syntheses without formation of a Si-C bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6568Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus atoms as the only ring hetero atoms
    • C07F9/65683Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus atoms as the only ring hetero atoms the ring phosphorus atom being part of a phosphine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus
    • C07F9/65742Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01MPROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
    • H01M10/00Secondary cells; Manufacture thereof
    • H01M10/05Accumulators with non-aqueous electrolyte
    • H01M10/052Li-accumulators
    • H01M10/0525Rocking-chair batteries, i.e. batteries with lithium insertion or intercalation in both electrodes; Lithium-ion batteries
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01MPROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
    • H01M10/00Secondary cells; Manufacture thereof
    • H01M10/05Accumulators with non-aqueous electrolyte
    • H01M10/056Accumulators with non-aqueous electrolyte characterised by the materials used as electrolytes, e.g. mixed inorganic/organic electrolytes
    • H01M10/0564Accumulators with non-aqueous electrolyte characterised by the materials used as electrolytes, e.g. mixed inorganic/organic electrolytes the electrolyte being constituted of organic materials only
    • H01M10/0566Liquid materials
    • H01M10/0567Liquid materials characterised by the additives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E60/00Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
    • Y02E60/10Energy storage using batteries

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Manufacturing & Machinery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Inorganic Chemistry (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Physics & Mathematics (AREA)
  • Materials Engineering (AREA)
  • Secondary Cells (AREA)

Abstract

The invention relates to a saturated heterocyclic ternary electrolyte, and a preparation method and an application thereof, wherein the electrolyte comprises boron trifluoride salt represented by the following general formula I: in the general formula I, the compound has the following structure,
Figure DDA0002809276970000011
represents a saturated heterocyclic ring containing at least one heteroatom in the ring; the heteroatom is selected from S, N, O, P, Se, Ca, Al, B or Si; m is a metal cation; e4Is a chain without or containing at least one atom; -E2‑OBF3M is connected to E4Or saturated heterocyclic rings
Figure DDA0002809276970000012
On any one atom of; e1、E2、E3Independently a chain structure or a structure containing a ring, which is free of, contains at least one atom; r is a substituent, and any H on the representative ring can be substituted by the substituent. The boron trifluoride salt can be used as an additive in a battery, can be applied to a liquid battery, a mixed solid-liquid battery, a semi-solid battery, a gel battery, a quasi-solid battery and an all-solid battery, and has a good effect.
Figure DDA0002809276970000013

Description

Ternary electrolyte containing saturated heterocycles, and preparation and application thereof
Technical Field
The invention relates to the technical field of batteries, in particular to a saturated heterocyclic ternary electrolyte and preparation and application thereof.
Background
The electrolyte is the important and necessary constitution of battery, and the battery has advantages such as high energy density, high voltage, the number of cycles is many, storage time is long, since commercialization, by the wide application in each aspect such as electric automobile, energy storage power station, unmanned aerial vehicle, portable equipment, no matter which kind of direction of application, all urgent needs improve the energy density and the circulation performance of battery under the prerequisite of guaranteeing battery security.
The currently developed liquid battery mainly comprises a positive electrode, a negative electrode, an electrolyte and a diaphragm, and the improvement of the energy density of the battery is to improve the working voltage and the discharge capacity of the battery, namely, a high-voltage high-capacity positive electrode material and a low-voltage high-capacity negative electrode material are matched for use; the improvement of the cycle performance of the battery is mainly to improve the stability of an interface layer formed between an electrolyte and a positive electrode and a negative electrode.
Taking a liquid lithium battery as an example, commonly used cathode materials include high voltage Lithium Cobaltate (LCO), high nickel ternary (NCM811, NCM622, NCM532, and NCA), Lithium Nickel Manganese Oxide (LNMO), lithium rich (Li-rich), and the like; common negative electrode materials include metallic lithium, graphite, silicon carbon, silicon oxycarbide, and the like; the commonly used diaphragm is mainly a polyethylene porous membrane or a polypropylene porous membrane; the liquid electrolyte is a mixture of a non-aqueous solvent and a lithium salt, and is classified into a carbonate liquid electrolyte and an ether liquid electrolyte according to the type of the solvent, and the salt mainly comprises lithium hexafluorophosphate, lithium perchlorate, lithium bis (trifluoromethyl) sulfonimide, lithium difluorooxalate phosphate and the like. The carbonate and ether solvents have narrow electrochemical windows and are easily oxidized and decomposed by high-voltage anode materials, so that the gas generation is serious, the liquid electrolyte is gradually consumed, and the battery rapidly loses efficacy. At present, two solutions are mainly provided, namely, a functional additive is added into the liquid electrolyte, and the liquid electrolyte is partially or completely replaced by a solid electrolyte.
According to the first method, some functional additives such as fluoroethylene carbonate and vinylene carbonate are added into the liquid electrolyte, a passivation layer is formed on the surface of the electrode in the first-cycle charging and discharging process, the decomposition of the electrode on the liquid electrolyte is inhibited, the discharge specific capacity of the battery is improved, and the cycle life of the battery is prolonged. However, the conventional liquid electrolyte additive does not contain dissociable ions, and only ions of the positive electrode can be consumed to form a surface passivation layer which only conducts ions and does not conduct ions, and if the formed passivation layer is unstable, the passivation layer is continuously destroyed and formed along with the increase of the cycle number, so that active lithium ions in the battery are continuously consumed, the first-cycle discharge capacity of the battery is low, the capacity attenuation is serious, and the battery still loses efficacy quickly. If the functional groups are combined with the groups capable of providing ions, the added salt/additive can form a passivation layer which conducts ions and has good stability on the surface of the electrode, and the liquid electrolyte with a narrow electrochemical window can be applied to a high-voltage battery system due to less consumption of ions from the positive electrode.
For method two, the liquid electrolyte is partially or fully replaced with a solid electrolyte. The solid electrolyte mainly comprises a polymer electrolyte, an inorganic oxide electrolyte and a sulfide electrolyte. The sulfide electrolyte is extremely sensitive to air and is easy to generate hydrogen sulfide, the electrochemical window is narrow, and the sulfide electrolyte is unstable to an anode material of an oxide; the oxide electrolyte has too high hardness and high brittleness; the electrochemical window of the polymer electrolyte is not wide, the conductivity is low, and the ion transference number is low. Therefore, the currently used electrolyte is still mostly a liquid electrolyte or a semi-solid electrolyte, and the secondary battery is mostly a liquid battery or a semi-solid battery. Sodium ion batteries also suffer from similar problems.
One of the groups of the Applicant has been working on compositions containing-OBF obtained by substitution of one hydroxyl group-OH3Compounds of the M group were studied. Due to [ -OBF [ ]3]-Is a strongly polar group capable of forming a salt structure with a cation, thus, -OBF3M has a strong sense of presence in one molecular structure, which may change the properties of the entire molecular structure. In the prior art, BF-containing samples were also only investigated by very individual researchers3Compounds of the group were studied sporadically and all contained only one BF3The group is researched, at present, no great results are obtained, and no results of industrial application are found; the prior art is directed to-O-BF3Investigation of the M group, let alone three-OBF3Studies of the M group are published. This is also because-OBF3M is strongly present, if-OBF is added to the molecule3The number of M may vary unpredictably in the overall properties of the overall molecular structure, and thus research teams may be able to conduct procedures involving two or more-OBFs3M research, resistance is greatly increased, time cost and economic cost are extremely high, and results are not well predicted, so that the research team only always contains one-OBF3M was studied. Even if the pair contains one-OBF3M is researched, and the prior art is few, so that the reference value is small, and the research on three groups does not have any reference source. The present research team also discovered unexpectedly in occasional studies-OBF containing trihydroxy substitutions3M organic matter is applied to batteries in liquid electrolyte and solid electrolyte, and the prepared batteries have excellent performance and surprising effect after being tested, so that a specially established team carries out special research on trisubstituted-OBF3M, and obtains better research results.
More importantly, the present application is directed to-OBF3The structure of M attached to a heterocycle, especially a saturated heterocycle, was independently studied. This is because the chemical properties such as electrical properties of the hetero atoms themselves are also quite specific, and their presence on the ring affects the chemical and physical properties of the entire ring, including the structure of the carbocyclic ring, aromatic ring, and chainAnd so on, are substantially different from each other, so that the association or deductibility between each other is uncertain. Thus, the-OBF is attached to a saturated heterocyclic ring3M, it is possible to produce effects different from those of other structures, in particular the connection of three-OBFs3M, it may have a more unexpected superior effect. The subject of the present application is therefore identified as having the-O-BF attached directly or indirectly to the saturated heterocycle3M, i.e. the main body of the ring is independently studied by distinguishing it from aromatic, carbocyclic and unsaturated rings, etc., so as to more specifically and definitely determine-O-BF3Specific case when M is linked to a saturated heterocycle.
Disclosure of Invention
The invention provides a saturated heterocyclic ternary electrolyte and preparation and application thereof aiming at overcoming the defects in the prior art.
The purpose of the invention is realized by the following technical scheme:
one aspect of the present invention is to provide a ternary electrolyte containing saturated heterocycles, the electrolyte comprising a saturated heterocyclic boron trifluoride salt represented by the following general formula I:
Figure BDA0002809276950000021
in the general formula I above, the compound of formula I,
Figure BDA0002809276950000022
represents a saturated heterocyclic ring containing at least one heteroatom in the ring; the heteroatom is selected from S, N, O, P, Se, Ca, Al, B or Si; m is a metal cation; e4Is a chain without or containing at least one atom; in the general formula I there is also one-E2-OBF3M, the-E2-OBF3M is connected to E4Or saturated heterocyclic rings
Figure BDA0002809276950000023
On any one atom of; e1、 E2、E3Independently is absent, at least oneA chain structure of atoms or a structure containing a ring; r is a substituent, any one H on the representative ring can be substituted by the substituent, and the substituent can be substituted by one H and can also be substituted by two or more H, if two or more H are substituted, the substituents can be the same or different, that is, each H can be substituted by the substituent defined in any one of R.
Further, in the general formula I, the saturated heterocyclic ring is a three-to twenty-membered ring.
Further, in the formula I, with-OBF3M is bonded to an atom comprising C, S, N, Si, P, B or O; preferably with-OBF3The atom to which M is directly attached is a carbon atom C.
Further, the heteroatom is selected from S, N, O, P, B or Si.
Further, H on any one C in the general formula I may be independently substituted by halogen, i.e. ring, substituent, E1、 E2Etc., and therefore, in the definitions described below, there are some technical features that do not specifically describe the substitution of any one C H by a halogen.
Further, in three-OBF of the formula I3In M, at least one is attached to a carbon atom other than the carbonyl carbon, which includes-C ═ O or-C ═ S.
Further, the substituent R is selected from H, halogen atoms (including F, Cl, Br, I), carbonyl, ester groups, aldehyde groups, ether oxy groups, ether thio groups, ═ O, ═ S, and,
Figure BDA0002809276950000031
Nitro, cyano, amino, amide, sulfonamide, sulfoalkane, hydrazino, diazo, alkyl, heteroalkyl, cyclic substituents, salt substituents, and those wherein any hydrogen H is substituted with a halogen atom. Wherein the ester group includes carboxylic acid esters, carbonic acid esters, sulfonic acid esters, and phosphoric acid esters; hydrocarbyl groups include alkyl, alkenyl, alkynyl, and alkenylalkynyl groups; heterohydrocarbyl is hydrocarbyl containing at least one non-carbon atom, including heteroalkyl, heteroalkenyl, heteroalkynyl, and heteroalkynynyl; the non-carbon atoms being selected from halogen, N, P, S, O,Se, Al, B and Si; the ring substituent comprises a ternary-eight-membered ring and a polycyclic ring formed by at least two monocyclic rings; the salt substituents include but are not limited to sulfate, sulfonate, sulfonimide, carbonate, thioether, oxoether, nitrogen, hydrochloride, nitrate, azide, silicate, phosphate.
Further, the carbonyl group is
Figure BDA0002809276950000032
The ester group is-R55COOR56、-R55OCOR54、-R55SO2OR56Or R55O-CO-OR56Or
Figure BDA0002809276950000033
Amino is ═ N-R21
Figure BDA0002809276950000034
or-CH ═ N-R81Amide is
Figure BDA0002809276950000035
Sulfonamide group of
Figure BDA0002809276950000036
Figure BDA0002809276950000037
The sulfoalkane is
Figure BDA0002809276950000038
Diazo is-N ═ N-R16With an ether oxygen radical of-R31OR32The etherthio radical is-R31SR32(ii) a Wherein R is2、R3、R16、R21、R22、R23、R24、R25、R31、R32、R40、R41、R42、R43、R44、R45、 R46、R50、R51、R52、R54、R55、R56、R57、R79、R80、R81Independently an alkyl, heteroalkyl, alkenyl, heteroalkenyl, alkynyl, heteroalkynyl, ring, or a group in which H on any one of these groups, C, is substituted with a halogen, a heteroalkane/alkene/alkynyl being an alkane/alkene/alkynyl containing at least one of the non-carbon atoms; and R is2、R3、R16、R21、R23、R25、R40、R41、R42、R79、R80、R81Can also be H, R22、R24、R31、R44、R45、R50、R55Can also be absent; the group directly attached to N or O can also be a metal ion, such as R25、R32、R40、R42、R56、R57、R79Etc. may be metal ions, such as Li+、Na+、K+、Ca2+And the like.
Further, E1、E2Or E3Selected from the group consisting of a carbonyl group, a carbonyl-containing group, an ester-containing group, an alkyl group, a heteroalkyl group, an alkenyl group, a heteroalkenyl group, an alkynyl group, a group containing a cyclic structure, a substituted aryl group, a substituted heteroaryl,
Figure BDA0002809276950000039
or-N-R6-, said heteroalkenyl group includes a structure containing a carbon-carbon double bond C ═ C and a structure containing a carbon-carbon double bond C ═ N, R4、R5And R6Independently of R in the preceding paragraph2、R3The species defined in (1) are identical. E4Is a chain structure without or containing 3 free connecting bonds and at least one atom, the 3 free connecting bonds are respectively connected with a saturated heterocyclic ring and E1And E2Is connected, if E1And/or E2If not, then E4Free bond of (A) and-OBF3And M is connected.
Further, in the general formula i, the saturated heterocyclic ring is a three-membered ring, a four-membered ring, a five-membered ring, a six-membered ring, a seven-membered ring, an eight-membered ring, a nine-membered ring, a ten-membered ring, a twelve-membered ring, a fourteen-membered ring, a sixteen-membered ring and an eighteen-membered ring; preferably, the saturated heterocycle is three-membered, four-membered, five-membered, six-membered, seven-membered, eight-membered, sixteen-membered and eighteenth-membered. Preferably, the three-membered ring: contains a heteroatom; a four-membered ring: containing 1 or 2 heteroatoms; five-membered ring: containing 1,2, 3 or 4 heteroatoms; a six-membered ring: containing 1,2, 3, 4, 5 or 6 heteroatoms; seven-, eight-, nine-membered rings: containing 1,2, 3 or 4 heteroatoms; ten-, twelve-, fourteen-membered rings: containing 1,2, 3, 4 or 5 heteroatoms; sixteen and eighteen membered rings: containing 1,2, 3, 4, 5 or 6 heteroatoms; any one of the heteroatoms in each heterocycle is independently selected from S, N, O, P, Se, B, or Si.
Further, in the general formula I, the saturated heterocyclic ring is selected from a ternary heterocyclic ring containing 1O, 1N or 1S, a quaternary heterocyclic ring containing 1O, 1S, 1N, 2O, 2N or both 1N and 1O, a five-to eight-membered heterocyclic ring containing 1S, 1N, 1O, 1 Si, 1P, 2S, 2N, 2O, 3O, simultaneously containing 1O and 1S, simultaneously containing 1O and 1N, simultaneously containing 1N and 1S, simultaneously containing 1 Si and 1N, simultaneously containing 1O and 1P, simultaneously containing 1N and 1P, simultaneously containing 2N and 1P, simultaneously containing 3N and 3P, simultaneously containing 2O and 1P or simultaneously containing 2O and 1 Si; a ten-to sixteen-membered heterocycle containing 1O, 1S, 1N, 3N, 4O, 4S, 4N, 5O or 5S, or an eighteen-membered heterocycle containing 5O, 5S, 6O, 6S or both 5O and 1N, in each of which there are two-OBFs3M is directly or indirectly attached to any one or two of the heterocyclic ring atoms. More preferably, the saturated heterocyclic ring includes, but is not limited to:
Figure BDA0002809276950000041
Figure BDA0002809276950000042
h on any one C in the saturated heterocyclic ring can be independently substituted by the substituent R.
Further, the general formula i includes, but is not limited to, the following compounds:
Figure BDA0002809276950000043
Figure BDA0002809276950000044
Figure BDA0002809276950000051
Figure BDA0002809276950000052
in the above structure, Q1、Q2、Q3All indicate-OBF3M; e in each ring structure1、E2、E3And E4Independently in accordance with any one of the preceding paragraphs; any one H on each saturated heterocycle may be independently selected from A1Or A2Any one substituent of (A), A1、A2Are each independently selected from any one of the substituents defined in said substituent R in any of the above paragraphs.
Further, in the substituent A1、A2Or in R, the halogen atom comprises F, Cl, Br and I. R2、R3Independently H, methyl or ethyl; r21、R22、R23、R24、R25、R31、R32、R40、R41、R42、R43、R44、R45、R46、 R50、R51、R52、R54、R55、R56、R57、R79、R80、R81Independently an alkyl group containing 1-20 atoms, a heteroalkyl group containing 1-15 atoms, an alkenyl group containing 1-20 atoms, a heteroalkenyl group containing 1-15 atoms, or a CN containing group, and R22、R24、 R31、R44、R45、R50、R55Can also be absent, R21、R23、R25、R40、R41、R42、R79、R80、R81Can also be H, R22、R24、R31、R44、R45、R50、R55Can also be absent; the group directly attached to N or O can also be a metal ion; wherein the ester group can also be selected from-OCH2COOEt or-CH2(CH2)6COOEt; the amide can also be selected from
Figure BDA0002809276950000053
R46Can also be N (CH)2CH2CH2CH3)2;R21Can also be NO22-methylphenyl, 2, 4-dimethylphenyl, 2-methyl-3-chloro-phenyl, 3-trifluoromethylphenyl, CH2COOCH3Cyclohexane, 1, 3-cyclohexadiene, thiazole,
Figure BDA0002809276950000054
Or a fluorotolyl group; r35Can also be selected from the group consisting of octyl, decyl, octadecyl, and-O- (CH)2)2CH(CH3)2(ii) a The carbonyl group can also be selected from the group consisting of-CO-CH (CH)3)CH2CH(CH3)CH2CH3or-CO-CH (CH)3)CH2CH(CH3)CCl2CH2Cl。
Diazo is-N ═ N-R16,R16Is phenyl or phenyl with methyl, halogen atom or nitro connected.
Cyano radicals selected from-CN, -CH2CN、-SCH2CH2CN、-N(CH3)CH2CH2CN or-CH2CH2CN。
The alkyl group includes methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, n-pentyl, isopentyl, sec-pentyl, neopentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecylAlkyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, -CH (CH)3)2、-C(CH3)2CH2C(CH3)3、-C(CH3)2CH2CH3Etc. fall within the scope defined by the alkyl group.
Heteroalkyl is an alkyl group containing at least one of the heteroatoms, preferably the heteroalkyl group comprises-CH2NO2、-Z1CF3、 -CH2Z1、-CH2Z1CH3、-CH2CH2Z1、-Z1(CH2CH3)2、-CH2N(CH3)2、-CH2CH2-O-NO2、-CH2S-S-CH3、 -CO-CH2Cl、-CO-CH2Br、-CH2Z1CH(CH3)2、-CH(Z1CH2CH3)2、-CH2CH(SCH2CH3)2、 -CH2Z1CH(CH3)2、-COCH2CH(CH3)2、-OCH2(CH2)6CH3、-CH2(CH3)Z1CH3、 -CH2(CH3)Z1CH2CH3、-CH2CH2Z1CH3、-CH2CH(CH3)Z1CH3、-CH(CH3)CH2Z1CH3、 -CH2CH2Z1CH2CH3、-CH2CH2CH2Z1CH3、-CH2CH2CH2Z1CH2CH3、-CH2CH(CH3)CH2Z1CH3、 -Z1CH2CH2Si(CH3)3
Figure BDA0002809276950000055
The alkenyl group includes vinyl, 1-propenyl, butenyl, pentenyl, hexenyl, heptenyl, octenyl, nonenyl, decenyl, undecenyl, dodecenyl, tridecenyl, tetradecenyl, pentadecenyl, hexadecenyl, heptadecenyl, octadecenyl, such as 1, 3-hexadienyl, -C (CH)3)=CH2、-CH2CH=CH(CH3)2、-CH2CH=CH-CH2CH3、-C(CH3)=CH2
Figure BDA0002809276950000061
And the like belong to the alkenyl category.
Heteroalkenyl is alkenyl containing at least one of the heteroatoms, preferably selected from the group consisting of-N ═ CHCH3、 -OCH2CH=CH2、-CH2-CH=CH-Z1CH3、-C(CH3)=CHCH3、-CH2CH=C(CH3)2、 -C(CH3)=CHCOCH3、-COCH=CHCH2CH3、-C(CH3)=CH2、-CH=CHCH2-CH2Z1CH3、 -CH2-CH=CH-Z1CH3
Alkynyl includes ethynyl, propynyl, butynyl, pentynyl, hexynyl, heptynyl.
Heteroalkynyl is alkynyl containing at least one of said heteroatoms, preferably heteroalkynyl includes-C ≡ CCH2CH2CH2Z1CH2CH3、 -C≡CCH2Z1CH2CH3、-C≡C-Si(CH3)3
Alkenynyl is a structure containing at least one double bond and at least one triple bond, preferably alkenynyl includes-C ≡ CCH ═ CHCH3、 -C≡CCH2CH=CHCH2Z1CH3、-C≡CCH2CH2CH=CHCH3
Heteroalkynyls are alkynyls containing at least one of the heteroatoms mentioned, preferably heteroalkynyls selected from the group consisting of-CH ═ C (CN)2、 -C≡CCH2CH=CHCH2Z1CH3
The ring substituents include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, and polycyclic; wherein: the cyclopropyl group is selected from a cyclopropyl group, an oxirane group, a thiirane group, a cycloazethane group or a cyclopropene group; the cyclobutyl group is selected from the group consisting of cyclobutyl and cyclobutylheteroalkyl (e.g.
Figure BDA0002809276950000062
Etc.), cyclobutenyl; the cyclopentyl group is selected from cyclopentyl group, cyclopentenyl group, cyclopentadienyl group, pyrrolyl group, dihydropyrrolyl group, tetrahydropyrrolyl group, furyl group, dihydrofuryl group, tetrahydrofuryl group, thienyl group, dihydrothienyl group, tetrahydrothienyl group, imidazolyl group, thiazolyl group
Figure BDA0002809276950000063
Dihydrothiazolyl, tetrahydrothiazolyl, isothiazolyl, dihydroisothiazolyl, pyrazolyl, oxazolyl
Figure BDA0002809276950000064
Dihydrooxazolyl, tetrahydrooxazolyl, isoxazolyl
Figure BDA0002809276950000065
Dihydroisoxazolyl, tetrahydroisooxazolyl, triazolyl, tetrazolyl, triazolyl, tetrazolyl, and tetrazolyl,
Figure BDA0002809276950000066
Figure BDA0002809276950000067
Figure BDA0002809276950000068
The cyclohexyl is selected from: phenyl, pyridine, dihydropyridine, tetrahydropyridine, pyrimidine, p-diazepine, cyclohexane, cyclohexenyl, 1, 3-cyclohexadiene, 1, 4-cyclohexadiene, piperidine, pyran, dihydropyran, tetrahydropyran, morpholine, piperazine, pyrone, pyridazinePyrazine, triazine, dihydropyrimidine, tetrahydropyrimidine, hexahydropyrimidine, thiopyran, dihydrothiopyran
Figure BDA0002809276950000069
Tetrahydrothiopyrans, dithianes
Figure BDA00028092769500000610
Figure BDA00028092769500000610
1, 2-dithianes
Figure BDA00028092769500000611
Figure BDA00028092769500000611
1, 4-dithianes, oxazolidines (e.g. [1,3 ]]Oxazolidines
Figure BDA00028092769500000612
)、
Figure BDA00028092769500000613
Figure BDA00028092769500000614
Figure BDA00028092769500000615
The polycyclic ring is selected from: biphenyl, naphthyl, anthryl, phenanthryl, quinonyl, pyrenyl, acenaphthenyl, carbazolyl, indolyl, isoindolyl, quinolyl, purinyl, alkanyl, benzoxazole,
Figure BDA0002809276950000071
Figure BDA0002809276950000072
Wherein, Z is as defined above1is-O-, -S-S-),
Figure BDA0002809276950000073
Wherein R is15、R90、R91、R92Independently selected from H, methyl, ethyl, propyl, isopropyl, butyl, fluoromethyl, fluoroethyl, methoxy, ethenyl, propenyl, or metal ions. On any one of the above-mentioned ring substituentsEach of the H-bearing atoms of (a) may independently be attached to a first substituent of the same type as that defined for substituent R; more preferably, the first substituent is selected from the group consisting of H, halogen atom, methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, n-pentyl, isopentyl, sec-pentyl, neopentyl, fluoromethyl, fluoroethyl, methoxy, ethoxy, nitro, alkenyl, alkynyl, ester, sulfonate, sulfoalkane, amide, cyano, aldehyde, -SCH3、-COOCH3、COOCH2CH3、-OCF3、=O、-CO-N(CH3)2
Figure BDA0002809276950000074
Or a substituent in which H on any one C of these groups is substituted with halogen; r10Selected from methyl, ethyl or propyl.
Any atom with H in any ring structure of the ring substituents of the ring may be independently linked to the saturated heterocycle via the following linking groups: single bond (direct bond, i.e., ring to ring direct bond), methyl (-CH)2-), ethyl (-CH)2CH2-), propyl, butyl, ethylene, propylene, butylene, acetylene, propyne, -COO-, -COCH2-、 COOCH2CH2-、-CH2OCH2-、-CH2OCH2CH2-、-OCH2CH2O-、-OCH2-、-OCH2CH2-、-N=N-、 -S-、-S-S-、-O-、-CH=CH-COO-CH2CH2-、-CH2OOC-、-CH=CH-CO-、-CH2N(CH3)CH2-、
Figure BDA0002809276950000075
Figure BDA0002809276950000076
Connecting; r14Selected from H, methyl, ethyl or propyl, R83Selected from alkyl or cyclic; r is47、R93、R97Is independently selected from the group consisting ofA linking group.
R20Independently selected from said linking groups, preferably R20Is none (i.e. singly bonded), -CH2-or-CO-, R21Is H, hydrocarbyl, heterohydrocarbyl or cyclic;
Figure BDA0002809276950000077
and
Figure BDA0002809276950000078
independently a monocyclic ring or a polycyclic ring consisting of at least two monocyclic rings, preferably, the monocyclic ring can be a 3-8 membered ring, which can be a saturated carbocyclic ring, a saturated heterocyclic ring, an unsaturated carbocyclic ring and an unsaturated heterocyclic ring, the polycyclic ring can be a fused ring, a bridged ring or a spiro ring; more preferably, the amount of the organic solvent is,
Figure BDA0002809276950000079
and
Figure BDA00028092769500000710
independently phenyl, cyclopropane, oxirane, cyclobutane, cyclopentane, cyclopentenyl, furan, dihydro/tetrahydrofuran, thiophene, dihydro/tetrahydrothiophene, pyrrole, dihydro/tetrahydrothiophene, thiazole, isothiazole, oxazole, isoxazole, pyridine, pyrimidine, piperidine, 1, 3-dioxacycloalkane, imidazole, pyrazine, pyridazine, p-diazabenzene, triazine, cyclohexane, cyclohexenyl, cycloheptane.
Further, E1、E2And E3Independently selected from the group consisting of none, carbonyl, keto, ester, -CH2-, ethyl, N-propyl, isopropyl, N-butyl, isobutyl, N-pentyl, isopentyl, sec-pentyl, neopentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, ethenyl, propenyl, butenyl, pentenyl, ethynyl, propynyl, butynyl, pentynyl, hexynyl, heptynyl, octenyl, nonenyl, decenyl, cyclohexyl, cyclopentyl, 1, 3-hexadienyl, -C ═ N-, -C (CH)3)2-、-CH(CH3)-、-CH(CF3)-、-C(CF3)2-、-CH2CH2CH(CH3)-、-Z'1CH2CH2-、-CH2CH(CH3)-、 -OCH2-、-CH=CH-CO-、-OCH2CH2CH2CO-、=N-CH2-CO-、-Z'1CH2CO-、-Z'1CH2CH2CO-、 -Z'1CH2CH2CH2CO-、-COOCH2CH2-、-CH(CH3)CO-、-CH(CH2Cl)-、-CH(OCH3)-、-CH(CHO)-、 -CH2COCO-、-C(CH3)2CH2CH2-、-O-CH2(CH2)4CH2-、-CH2CH2CO-、-CH2(CH2)5CO-、 -N=C(CH3)-、-O-(CH2)6-、-CH2Z'1CH2-、-CH2(CH3)Z'1CH2-、-CH2CH2Z'1CH2-、 -CH2CH(CH3)Z'1CH2-、
Figure BDA0002809276950000081
Figure BDA0002809276950000082
Figure BDA0002809276950000083
-(CH3)CHCH2CH2Z’1CH2-、-O-CH(CH3)-(CH2)4CH2-、
Figure BDA0002809276950000084
Figure BDA0002809276950000085
Figure BDA0002809276950000086
E4Selected from among,
Figure BDA0002809276950000087
Figure BDA0002809276950000088
Wherein, Z 'is'1is-O-, -S-S-, -COO-,
Figure BDA0002809276950000089
wherein R is11Is H, methyl, ethyl, propyl, isopropyl, butyl, ethoxy or methoxy, and the R is11Any one of hydrogen and H in (1) can be replaced by F or Cl; r59、R60Independently an alkyl group or a ring. R13、R96Independently selected from H, methyl, ethyl, propyl, butyl, pentyl, cyclopropyl, cyclopentyl, cyclohexyl, nitro, hexyl, thiazolyl, pyrrolyl, -CH (CH)3)2、 -CH2CH(CH3)2、-CH2CH2NO3、-CH2CH2CH(CH3)2
Figure BDA0002809276950000091
Wherein R is9Is nothing, methylene, -CH (CH)3)-Ph;R8、R12、R17、R18、R35、R85、R94、R95Independently selected from halogen atom, alkyl, fluoroalkyl, methoxyl, nitryl, aldehyde group, ketone group, ester group or-CH2-N(CH3)2Optionally R being attached to thiazolyl, pyrrolyl or phenyl Ph17Such as trifluoromethyl.
Further preferably, E1、E2Or E3Independently selected from the group consisting of none, -CH2-、-CH2CH2-、-CO-、-CH2CO-、-CH2CH2CO-、 -OCH2-、-OCH2CH2-、-CH2OCH2-、-CH2(CH2)12CO-、
Figure BDA0002809276950000092
Figure BDA0002809276950000093
R13Independently selected from methyl, ethyl, propyl, -CH (CH)3)2Cyclopropane, cyclopentane, cyclohexane, benzene ring and nitro; r17And R18Selected from among none, methyl, ethyl, halogen atoms, fluoromethyl, fluoroethyl, methoxy, nitro; e4Selected from among,
Figure BDA0002809276950000094
Figure BDA0002809276950000095
Further, M of the general formula I includes Na+、K+、Li+、Mg2+Or Ca2+Preferably Na+、K+Or Li+
Further, the general formula I is: a compound of formula i as described in any of the preceding paragraphs wherein H on any one of the C groups is substituted, either fully or partially, with halogen, preferably F.
Another aspect of the present invention is to provide a method for preparing an electrolyte according to any one of the above, wherein the method comprises reacting a saturated heterocyclic-containing ternary structure containing three-OH groups, a boron trifluoride compound and an M source to obtain a product containing three-OBF groups3M is a saturated heterocyclic boron trifluoride salt.
It is a further aspect of the present invention to provide an additive for use in a battery, the additive comprising the general formula I as described in any of the above paragraphs, i.e. comprising a saturated heterocyclic boron trifluoride salt as described in any of the above paragraphs.
The invention also provides an electrolyte, which comprises a liquid electrolyte, a gel electrolyte, a mixed solid-liquid electrolyte, a quasi-solid electrolyte and an all-solid electrolyte, wherein the liquid electrolyte, the gel electrolyte, the mixed solid-liquid electrolyte, the quasi-solid electrolyte and the all-solid electrolyte respectively and independently comprise the ternary electrolyte containing saturated heterocycles in any section, namely the ternary electrolyte comprises the general formula I in any section.
The invention also provides a battery, which comprises the saturated heterocyclic ternary electrolyte, a positive electrode, a negative electrode, a diaphragm and a packaging shell, wherein the saturated heterocyclic ternary electrolyte comprises a saturated heterocyclic ternary electrolyte; the battery comprises any one of a liquid battery, a mixed solid-liquid battery, a semi-solid battery, a gel battery, a quasi-solid battery and an all-solid battery.
A final aspect of the present invention is to provide a battery pack including the battery.
The invention has the following main beneficial effects:
the electrolyte in the present application creatively combines three-OBF3M is complexed in one compound, and is preferably-OBF3M is connected with carbon atom C, and the structural effect protected by the invention is more prominent.
1. Specifically, the boron organic compound can be used as an additive in a battery, can form a stable and compact passivation film on the surface of an electrode of the battery, prevents an electrolyte from being in direct contact with an electrode active substance, inhibits the decomposition of each component of the electrolyte, widens the electrochemical window of the whole electrolyte system, and can remarkably improve the discharge specific capacity, the coulombic efficiency and the cycle performance of the battery; in addition, the boron organic compound is an ionic conductor, is used as an additive, and consumes less active ions coming out of the positive electrode while forming a passivation layer on the surface of the electrode, so that the first coulombic efficiency and the first peripheral discharge specific capacity of the battery can be obviously improved. And when the electrolyte containing the boron organic compound, the existing high-voltage high-specific-volume positive electrode material and the low-voltage high-specific-volume negative electrode material are compounded into a battery, the electrochemical performance of the battery is improved. In addition, the structure of the application can be mixed with conventional additives for use, namely, a double additive or a multi-additive, and the battery using the double additive or the multi-additive shows more excellent electrochemical performance.
In addition, when the structure in the application is used in an electrolyte, the structure can act synergistically as an additive property and a salt property, so that the electrolyte has an excellent effect superior to that of a traditional additive, for example, when the structure is used as an additive, a stable passivation layer can be formed on the surface of an electrode in the battery cycling process, PEO or other components are prevented from being further decomposed, and the structure also has good ion transmission performance, so that the battery shows more excellent long-cycle stability and comprehensive effect.
2. The boron organic compound has the advantages of rich raw material sources, wide raw material selectivity, low cost, simple preparation process, mild reaction conditions and excellent industrial application prospect, and only needs to react a compound containing three-OH groups with boron trifluoride organic matters and an M source (M is a metal cation).
3. The lithium-ion battery can also adopt metals except the traditional lithium such as sodium and potassium to form salt, so that more possibilities are provided for later application, cost control or raw material selection, and the like, and the lithium-ion battery has great significance.
Drawings
FIGS. 1-12 are nuclear magnetic hydrogen spectra of products of some embodiments of the invention;
fig. 13 to 16 are graphs showing the effect of the circulation of boron trifluoride salt as an electrolyte additive according to the present invention.
Detailed Description
In order to make the objects, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions of the present invention will be clearly and completely described below with reference to specific embodiments of the present invention, and it is obvious that the described embodiments are some, but not all embodiments of the present invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
In the title and description of the invention, -OBF3M in M may be a monovalent, divalent, trivalent or polyvalent metal cation, if it is not a monovalent ion, -OBF3Is increased correspondingly to the valence of MAnd (4) mixing.
In the present invention, unless the position of the substituent to the substituted structure is explicitly indicated, it means that any atom in the substituent may be bonded to the substituted atom or structure, for example: if the substituent is
Figure BDA0002809276950000101
R91、 R92Respectively is a substituent on two benzene rings, then any carbon atom and R on any benzene91、R92Or R93(if R is91、 R92、R93Not absent) may be attached to a substituted saturated heterocyclic structure. Furthermore, where two linkages are present in a substituent, the linked structure may be linked to either linkage, e.g. if R93is-OCH2CH2The linkage on O can be either to the left or to the right phenyl ring, likewise the linkage on methylene is also possible.
In the present invention, if a group is desired to be attached to a two-part structure, it has two linkages or radicals to be attached, and if it is not explicitly indicated which two atoms are attached to the attached part, any one atom containing H may be attached. E if in the claims of this application1Is n-butyl due to E1Having 2 linkages to be linked (one with-OBF)3To which one is attached to the main structure) and n-butyl has only one bond at the terminus, then the other bond can be located on any of the 4 carbon atoms in n-butyl.
In the context of the present invention, a chemical bond is not drawn on an atom, but on a position where it intersects the bond, e.g. on the surface of a metal
Figure BDA0002809276950000102
Represents any one H on the ring and may be independently substituted by a substituent A1Substituted, and can replace one H and also can replace two or more H, and the substituents can be the same or different; for example, when a1 is a substituent such as ═ O, methyl, F or the like, the five-membered ringWherein any one or more H may be independently substituted with methyl, F, etc., and any one of C containing two H may be linked to ═ O, e.g., it may be
Figure BDA0002809276950000103
And the like.
The "Et" is ethyl. "Ph" is phenyl.
In the structural formulae of the present invention, when a group in the parentheses "()" is contained after a certain atom, it means that the group in the parentheses is connected to the atom before it. Such as-C (CH)3)2-is of
Figure BDA0002809276950000111
-CH(CH3) -is of
Figure BDA0002809276950000112
In this application, the xx group may have a bond to the substituted structure, or may have two or three, depending on the actual requirement. If it is a general substituent, it has only one bond, if it is E1、E2Or some R in the first substituent, etc., which has 2 or 3 linkages.
The "boron trifluoride-based compound" refers to boron trifluoride, a compound containing boron trifluoride, a boron trifluoride complex or the like.
The invention provides a ternary organic boron trifluoride salt serving as an electrolyte additive, namely the ternary organic boron trifluoride salt contains three-OBF3M is a group in which M is Li+Or Na+And so on. The ternary boron trifluoride salt can be applied to liquid batteries, and can also be excellently applied to gel batteries and solid batteries. The preparation method of the compound is simple and ingenious, and the yield is high. Namely, the boron trifluoride compound is obtained by reacting a raw material, a boron trifluoride compound and an M source, specifically, OH in the raw material participates in the reaction, and other structures do not participate in the reaction. The specific preparation method mainly comprises two methods:
adding an M source and a raw material into a solvent under the atmosphere of nitrogen/argon, mixing, reacting at 5-50 ℃ for 5-24 hours, and drying the obtained mixed solution under reduced pressure at 20-80 ℃ and the vacuum degree of about-0.1 MPa to remove the solvent to obtain an intermediate; adding boron trifluoride compounds, stirring and reacting at 5-50 ℃ for 6-24 hours, drying the obtained mixed solution under reduced pressure at 20-80 ℃ and under the vacuum degree of about-0.1 MPa to obtain a crude product, and washing, filtering and drying the crude product to obtain the final product, namely the ternary organic boron trifluoride salt, wherein the yield is 74-95%.
Secondly, under the atmosphere of nitrogen/argon, adding the raw materials and boron trifluoride compounds into a solvent, uniformly mixing, reacting for 6-24 hours at the temperature of 5-50 ℃, decompressing and drying the obtained mixed solution at the temperature of 20-80 ℃ and the vacuum degree of about-0.1 MPa to remove the solvent, and reacting to obtain an intermediate; adding an M source into a solvent, then adding the solvent containing the M source into the intermediate, stirring and reacting for 5-24 hours at 5-50 ℃ to obtain a crude product, directly washing the crude product or washing the crude product after drying under reduced pressure, and then filtering and drying to obtain a final product, namely the ternary organic boron trifluoride salt, wherein the yield is 74-95%.
In the above two specific preparation methods, the boron trifluoride compounds may include boron trifluoride diethyl etherate complex, boron trifluoride tetrahydrofuran complex, boron trifluoride dibutyl etherate complex, boron trifluoride acetic acid complex, boron trifluoride monoethyl amine complex, boron trifluoride phosphoric acid complex, and the like. M sources include, but are not limited to, metallic lithium/sodium platelets, lithium/sodium methoxide, lithium/sodium hydroxide, lithium/sodium ethoxide, butyl lithium/sodium, lithium/sodium acetate, and the like. The solvent is independently alcohol (some liquid raw materials can be simultaneously used as the solvent), ethyl acetate, DMF, acetone, hexane, dichloromethane, tetrahydrofuran, ethylene glycol dimethyl ether and the like. The washing can be carried out with a small polar solvent such as diethyl ether, n-butyl ether, n-hexane, cyclohexane, diphenyl ether, etc.
Example 1: raw materials
Figure BDA0002809276950000113
The preparation method comprises the following steps: 0.01mol of the starting material and boron trifluoride tetrahydrofuran complex (4.19g, 0.03mol) were mixed uniformly in 15ml of ethylene glycol dimethyl ether in a nitrogen atmosphere, and reacted at room temperature for 12 hours. The obtained mixed solution is decompressed and dried at 40 ℃ and under the vacuum degree of about-0.1 MPa to remove the solvent, and an intermediate is obtained. Dissolving lithium ethoxide (1.56g, 0.03mol) in 10ml ethanol, slowly adding the solution into the intermediate, stirring and reacting for 8 hours at 45 ℃, drying the obtained mixed solution under reduced pressure at 40 ℃ and a vacuum degree of about-0.1 MPa, washing the obtained solid with n-butyl ether for three times, and filtering and drying to obtain a product M1. The yield was 88%, and the nuclear magnetization is shown in FIG. 1.
Example 2: raw materials
Figure BDA0002809276950000114
The preparation method comprises the following steps: 0.01mol of the starting material and boron trifluoride diethyl etherate (4.26g,0.03mol) were mixed uniformly in 15ml of ethylene glycol dimethyl ether under an argon atmosphere, and reacted at room temperature for 12 hours. The obtained mixed solution is decompressed and dried at 30 ℃ and the vacuum degree of about-0.1 MPa to remove the solvent, and an intermediate is obtained. Adding 18.90ml of butyl lithium hexane solution (c is 1.6mol/L) into the intermediate, stirring and reacting for 6 hours at room temperature, drying the obtained mixed solution under reduced pressure at 40 ℃ and the vacuum degree of about-0.1 MPa, washing the obtained crude product with cyclohexane for 3 times, filtering and drying to obtain a product M2, wherein Q is OBF3And Li. The yield was 89%.
Example 3: raw materials
Figure BDA0002809276950000121
The preparation method comprises the following steps: 0.01mol of the starting material and lithium methoxide (1.14g,0.03mol) were mixed uniformly with 20ml of methanol under a nitrogen atmosphere, and reacted at room temperature for 8 hours. The obtained mixed solution is decompressed and dried at 40 ℃ and under the vacuum degree of about-0.1 MPa to remove the solvent, and an intermediate is obtained. Boron trifluoride tetrahydrofuran complex (4.19g, 0.03mol) and 10ml THF are added into the intermediate, the mixture is stirred and reacted for 6 hours at room temperature, the obtained mixed solution is decompressed and dried at 40 ℃ and the vacuum degree of about-0.1 MPa, the obtained solid is washed three times by isopropyl ether, and the product M3 is obtained after filtration and drying. Yield 79% and nuclear magnetization are shown in fig. 2.
Example 4: original sourceMaterial
Figure BDA0002809276950000122
The preparation method comprises the following steps: 0.01mol of the starting material and boron trifluoride tetrahydrofuran complex (4.19g, 0.03mol) were mixed uniformly in 15ml of THF (tetrahydrofuran) under an argon atmosphere, and reacted at room temperature for 12 hours. The obtained mixed solution is decompressed and dried at 30 ℃ and the vacuum degree of about-0.1 MPa to remove the solvent, and an intermediate is obtained. Adding 18.90ml of butyl lithium hexane solution (c is 1.6mol/L) into the intermediate, stirring and reacting for 6 hours at room temperature, drying the obtained mixed solution under reduced pressure at 40 ℃ and the vacuum degree of about-0.1 MPa, washing the obtained crude product with cyclohexane for 3 times, filtering and drying to obtain a product M4, wherein Q is OBF3And Li. The yield was 90%.
Example 5: starting materials
Figure BDA0002809276950000123
The preparation method comprises the following steps: 0.01mol of the starting material and sodium hydroxide (1.20g, 0.03mol) were mixed uniformly with 10ml of a methanol solution under a nitrogen atmosphere, and reacted at 10 ℃ for 8 hours. The obtained mixed solution is decompressed and dried at 40 ℃ and under the vacuum degree of about-0.1 MPa to remove the solvent, and an intermediate is obtained. Boron trifluoride diethyl etherate (4.26g,0.03mol) is added into the intermediate, 10ml of ethylene glycol dimethyl ether solvent is added, the mixture is stirred for 24 hours at room temperature, the obtained mixed solution is decompressed and dried at 40 ℃ and the vacuum degree of about-0.1 MPa, the obtained solid is washed three times by dichloromethane, and the product M5 is obtained after filtration and drying. The yield is 72%, wherein Q is OBF3Na。
Example 6: raw materials
Figure BDA0002809276950000124
Preparation: the product M6 was prepared from the starting material by the method of example 1. Yield 76% and nuclear magnetization are shown in figure 3.
Example 7: starting materials
Figure BDA0002809276950000131
Preparation: the product M7 was prepared from the starting material by the method of example 1. Yield 79% and nuclear magnetization are shown in fig. 4.
Example 8: raw materials
Figure BDA0002809276950000132
Preparation: the product M8 was prepared from the starting material by the method of example 3, wherein Q is OBF3And Li. The yield was 80%.
Example 9: raw materials
Figure BDA0002809276950000133
Preparation: the product M9 was prepared from the starting material by the method of example 2, wherein Q is OBF3And Li. The yield was 88%.
Example 10: starting materials
Figure BDA0002809276950000134
Preparation: the product M10 was prepared from the starting material by the method of example 4. Yield 86%, nuclear magnetization is shown in fig. 5.
Example 11: raw materials
Figure BDA0002809276950000135
Preparation: the product M11 was prepared from the starting material by the method of example 4, wherein Q is OBF3And Li. The yield was 87%.
Example 12: raw materials
Figure BDA0002809276950000136
Preparation: the product M12 was prepared from the starting material by the method of example 1. Yield 79% and nuclear magnetization are shown in fig. 6.
Example 13: raw materials
Figure BDA0002809276950000137
Preparation: the product M13 was prepared from the starting material by the method of example 3, wherein Q is OBF3And Li. The yield was 78%.
Example 14: starting materials
Figure BDA0002809276950000138
Preparation: the product M14 was prepared from the starting material by the method of example 2, wherein Q is OBF3And Li. The yield was 87%.
Example 15: raw materials
Figure BDA0002809276950000141
Preparation: the product M15 was prepared from the starting material by the method of example 1. Yield 88%, nuclear magnetization is shown in fig. 7.
Example 16: starting materials
Figure BDA0002809276950000142
Preparation: the product M16 was prepared from the starting material by the method of example 3, wherein Q is OBF3And Li. The yield was 82%.
Example 17: raw materials
Figure BDA0002809276950000143
Preparation: the product M17 was prepared from the starting material by the method of example 4. Yield 86%, nuclear magnetization is shown in fig. 8.
Example 18: raw materials
Figure BDA0002809276950000144
Preparation: the product M18 was prepared from the starting material by the method of example 1. The yield was 89%.
Example 19: raw materials
Figure BDA0002809276950000145
Preparation: the product M19 was prepared from the starting material by the method of example 2. Yield 83%, nuclear magnetization is shown in fig. 9.
Example 20: raw materials
Figure BDA0002809276950000146
Preparation: the procedure of example 3 was followed to produce M20 wherein Q is OBF3And Li. The yield was 82%.
Example 21: raw materials
Figure BDA0002809276950000147
Preparation: the product M21 was prepared from the starting material by the method of example 1. Yield 77%, nuclear magnetization is shown in fig. 10.
Example 22: starting materials
Figure BDA0002809276950000151
Preparation: the product M22 was prepared from the starting material by the method of example 3. Yield 86%, nuclear magnetization is shown in fig. 11.
Example 23: raw materials
Figure BDA0002809276950000152
Preparation: the product M22 was prepared from the starting material by the method of example 3. Yield 76% and nuclear magnetization are shown in figure 12.
Example 24
The saturated heterocyclic boron trifluoride salt provided by the invention is mainly used as an additive in an electrolyte (including liquid and solid), mainly plays a role in generating a stable passivation layer, and has ions capable of being dissociated, so that the ions provided by an electrode are less consumed in the process of forming the passivation layer, and the first efficiency and the cycle performance of a battery are obviously improved. The performance of the present application is described below by way of tests.
(1) Positive pole piece
Adding the active substance of the main material of the positive electrode, the electronic conductive additive and the binder into a solvent according to the mass ratio of 95:2:3, wherein the solvent accounts for the mass of the total slurryThe amount fraction is 65%, and the positive electrode slurry with certain fluidity is obtained after uniform mixing and stirring; and coating the anode slurry on an aluminum foil, drying, compacting and cutting to obtain the usable anode piece. Lithium cobaltate (LiCoO) is selected as the active material2LCO for short), lithium nickel cobalt manganese oxide (NCM811 is selected), lithium nickel cobalt aluminate (LiNi)0.8Co0.15Al0.05O2NCA for short), lithium nickel manganese oxide (LiNi)0.5Mn1.5O4Abbreviated LNMO), Na0.9[Cu0.22Fe0.3Mn0.48]O2(NCFMO for short), Carbon Nanotubes (CNT) and Super P are selected as the electron conductive additive, polyvinylidene fluoride (PVDF) is used as the binder, and N-methylpyrrolidone (NMP) is used as the solvent.
(2) Negative pole piece
Adding a main negative material active substance (except metal Li), an electronic conductive additive and a binder into solvent deionized water according to a ratio of 95:2.5:2.5, wherein the solvent accounts for 42% of the total slurry, and uniformly mixing and stirring to obtain negative slurry with certain fluidity; and coating the negative electrode slurry on copper foil, drying and compacting to obtain the usable negative electrode piece. Graphite (C), silicon carbon (SiOC450), metallic lithium (Li) and Soft Carbon (SC) are selected as the active materials, CNT and Super P are used as the conductive agents, and carboxymethyl cellulose (CMC) and Styrene Butadiene Rubber (SBR) are used as the binders.
The anode and cathode systems selected by the invention are shown in table 1:
TABLE 1 Positive and negative electrode systems
Positive and negative electrode system of battery Positive electrode main material Negative electrode main material
A1 LCO SiOC450
A2 NCM811 SiOC450
A3 NCM811 Li
A4 NCA C
A5 LNMO C
A6 LCO Li
A7 NCFMO SC
(3) Preparation of electrolyte
M1-M23, organic solvent, conventional salt and conventional additives are mixed uniformly to obtain series electrolytes E1-E23, wherein the organic solvent is Ethyl Methyl Carbonate (EMC), dimethyl carbonate (DMC), diethyl carbonate (DEC), Ethylene Carbonate (EC) and Propylene Carbonate (PC). Namely, the conventional additives are fluoroethylene carbonate (FEC), Vinylene Carbonate (VC), trimethyl phosphate (TMP), ethoxypentafluorocyclotriphosphazene (PFPN), and vinyl sulfate (DTD); the conventional salts are lithium bis (oxalato) borate (LiBOB), lithium difluoro (oxalato) borate (LiODFB), bis (oxalato) borateLithium fluorosulfonylimide (LiFSI) and lithium hexafluorophosphate (LiPF)6) Lithium bis (trifluoromethyl) sulfonimide (LiTFSI), sodium hexafluorophosphate (NaPF)6). The specific components and ratios are shown in table 2.
Table 2 electrolytes formulated as additives in the present application
Figure BDA0002809276950000161
Note: 1M means 1 mol/L.
Comparison sample: and replacing M1-M23 with blanks according to the proportion of E1-E23 (namely, not adding M1-M23), thus obtaining corresponding conventional electrolyte comparison samples L1-L23.
(4) Button cell assembly
Electrolyte series E1-E23 containing the structure of the embodiment as an additive and conventional electrolytes L1-L23 are assembled into a button cell in a comparative way, and the details are as follows: negative electrode shell, negative electrode pole piece, PE/Al2O3A button cell is assembled by a diaphragm, an electrolyte, a positive pole piece, a stainless steel sheet, a spring piece and a positive shell, and a long circulation test is carried out at room temperature, wherein the circulation modes are 0.1C/0.1C 1 week, 0.2C/0.2C 5 week and 1C/1C 44 week (C represents multiplying power), the positive pole piece is a circular sheet with the diameter of 12mm, the negative pole piece is a circular sheet with the diameter of 14mm, the diaphragm is a circular sheet with the diameter of 16.2mm, and is a commercial Al circular sheet2O3a/PE porous separator.
The battery systems prepared from E1 to E23 were batteries 1 to 23, respectively, and the battery systems prepared from L1 to L23 were comparative batteries 1 to 23, respectively. The specific configuration and voltage range of the cell are shown in table 3. The results of the first cycle specific discharge capacity, the first cycle efficiency, and the capacity retention rate at 50 cycles of the batteries 1 to 23 and the comparative batteries 1 to 23 at room temperature are shown in table 4.
Table 3 arrangement and test mode of example and comparative example cells
Figure BDA0002809276950000171
Table 4 comparison of test results of example cell and comparative example cell
Figure BDA0002809276950000172
Figure BDA0002809276950000181
From the test results of the batteries in the above examples and comparative batteries, in the button battery, when the positive and negative electrode systems are the same, the first cycle efficiency, specific discharge capacity and capacity retention rate of the battery using the structure M1-M23 of the invention as an electrolyte additive are much better than those of the battery without the electrolyte additive, and the performance of the battery is superior to that of the conventional additive at present. In addition, the battery shows more excellent cycle performance using the boron trifluoride salt additive of the present application in the presence of conventional additives, showing a synergistic effect.
In addition, the application also shows the effect graph of some examples as additives. FIGS. 13-16 are graphs comparing the performance of battery 8/14/20/22 made with example 8/14/20/22 as an electrolyte additive to a corresponding comparative battery 8/14/20/22 that did not contain example 8/14/20/22 of the present invention. The figures also show that the structure of the application has excellent effect. In addition, in the circulation diagram, there are small squares on the upper surface
Figure BDA0002809276950000191
The lines of (A) represent the cells of the examples, with small circles
Figure BDA0002809276950000192
The lines representing the cells of the comparative examples represent the cells of the comparative examples, and it can be seen that the lines representing the cells of the examples are all above the lines representing the cells of the comparative examples, and the cells of the examples have better effects.
In summary, the first cycle efficiency, specific discharge capacity, capacity retention rate, and other properties have a direct and significant impact on the overall performance of the battery, which directly determines whether the battery can be used. Therefore, it is the goal or direction of many researchers in this field to improve these properties, but in this field, the improvement of these properties is very difficult, and generally about 3-5% improvement is a great progress. In the early experimental data, the data are surprisingly found to be greatly improved compared with the conventional data, particularly when the additive is used as an electrolyte additive, the performance is improved by about 5-30%, and the additive and the conventional additive are combined to be used for showing better effect. More importantly, the structural type of the application is greatly different from the conventional structure, so that a new direction and thought are provided for the research and development in the field, a large space is brought for further research, and the application can also have multiple purposes; has great significance.
Example 25
For further study and understanding of the structural properties in the present application, the applicant evaluated the effect of the following 4 structures as liquid electrolyte additives on the long cycle performance of the battery at room temperature. The structure of the present application was selected from the structure in example 22 (i.e., M22), and the following 4 comparative example structures were structure W1, structure W2, structure W3, and structure W4, respectively.
Figure BDA0002809276950000193
The effects of W1-W4 and M22 on the long-cycle performance of the cell at room temperature were evaluated by using them as liquid electrolyte additives, respectively.
(1) Liquid electrolyte configuration
Tables 5W 1 to W4, and liquid electrolytes S1 to S5 in which M22 was added as an additive
Figure BDA0002809276950000194
Wherein S0 is a control group.
(2) Button cell assembly
The obtained liquid electrolytes S0 to S5 were assembled into button cells, and the sizes of the positive and negative electrodes, the separator, the assembly method, and the battery cycle were the same as those of the button cell shown in "one" of embodiment 24, i.e., batteries Y0 to Y5, respectively. The specific configuration, cycling profile and voltage range of the cell are shown in table 6 and the test results are shown in table 7.
Watch 6 button cell assembling and testing mode
Figure BDA0002809276950000195
Figure BDA0002809276950000201
TABLE 7 test results of the batteries
Figure BDA0002809276950000202
The test results of the batteries Y0-Y5 show that the first efficiency, the 1-50-cycle discharge specific capacity and the capacity retention rate of the batteries can be improved by using the batteries W1-W4 and M22 as liquid electrolyte additives. However, compared with W1-W4, M22 has more obvious improvement on the first efficiency and first cycle specific discharge capacity of the battery, probably because W1 contains 1-OBF3M, W2, W4 contain-BF3And without lithium, -OLi in W3 compared to-OBF3Li having a low degree of dissociation and containing three-OBF3M22 of M contains a lithium source, and lithium ions extracted from the positive electrode are less consumed in the process of forming a good passivation layer, so that the first-effect and first-cycle discharge specific capacity and capacity retention rate of the battery are improved. The applicant is still in further research with a clearer and more clear mechanism. However, in any case, it is certain that the OBF3The presence and amount of M has a substantial effect on battery performance.
In the present invention, the structures in examples 1 to 23 were selected as representative to explain the production method and effects of the present application. Other structures not shown are all very effective and similar to examples 1-23, and other structures not shown can be prepared by the method described in any of examples 1-5. The manufacture thereofThe preparation method is that the raw material, boron trifluoride compounds and M source react to obtain the product boron trifluoride organic salt, namely-OH in the raw material is changed into-OBF3M, M may be Li+、Na+Etc., and the other structures are not changed. In addition, many research teams of the applicant have already made serial effect tests, which are similar to the effect in the above embodiments, such as: from raw materials
Figure BDA0002809276950000203
Figure BDA0002809276950000204
Figure BDA0002809276950000211
Figure BDA0002809276950000212
The boron trifluoride salt prepared by the method has good effect, but only partial structural data are recorded due to space relation.
In the present invention, it is also noted that (i) -OBF3-BF of M3It must be bonded to the oxygen atom O, which is in turn bonded by a single bond to the carbon atom C, so that O cannot be a ring-located oxygen. If O is bonded to N, S or another atom, or if O is located on a ring (or if O is bonded to another two groups), the structure is greatly different from the present application, and therefore, it cannot be predicted whether such a structure can be applied to the electrolyte of the present application, what effects and application scenarios are expected, and therefore, the inventors of the present invention will conduct independent studies on these structures, and will not conduct much discussion here; ② the structure does not contain sulfydryl.
In the present application, both of the above cases need to be satisfied, and if not, the properties of the present application are greatly different from those of the present application, so that the application scene or effect after the change is not well predicted, and may be greatly changed, and if valuable, the present inventors will make a special study separately later.
It should be noted that, the applicant has performed a great number of tests on the series of structures, and sometimes, for better comparison with the existing system, there are cases where the same structure and system are tested more than once, and therefore, there may be some error in the tests performed at different times.
In addition, the raw materials of the invention can be obtained by purchase or simple preparation, are extremely basic in the field of organic chemistry, have no difficulty, and therefore the raw material structure is conventional and is not within the protection scope of the invention.
Finally, it should be noted that: the above-mentioned embodiments are only used for illustrating the technical solution of the present invention, and not for limiting the same; although the present invention has been described in detail with reference to the foregoing embodiments, it should be understood by those of ordinary skill in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some or all of the technical features may be equivalently replaced; and the modifications or the substitutions do not make the essence of the corresponding technical solutions depart from the scope of the technical solutions of the embodiments of the present invention.

Claims (12)

1. A ternary electrolyte comprising saturated heterocycles, characterized in that: the electrolyte comprises saturated heterocyclic boron trifluoride salt represented by the following general formula I:
Figure FDA0002809276940000011
in the general formula I above, the compound of formula I,
Figure FDA0002809276940000012
represents a saturated heterocyclic ring containing at least one heteroatom in the ring; the heteroatom is selected from S, N, O, P, Se, Ca, Al, B or Si; m is a metal cation;
E4is a chain without or containing at least one atom;
-E2-OBF3m is connected to E4Or a saturated heterocyclic ring
Figure FDA0002809276940000013
On any one atom of;
E1、E2、E3independently a chain structure or a structure containing a ring, which is free of, contains at least one atom;
r is a substituent, any one H on the substituent can be substituted by the substituent, and the substituent can be substituted by one H and can also be substituted by two or more H, if two or more H are substituted, the substituents can be the same or different.
2. The electrolyte of claim 1, wherein: in the general formula I, the saturated heterocyclic ring is a three-to twenty-membered ring;
preferably, in the formula I, with-OBF3The atom to which M is directly bonded is a carbon atom C;
more preferably, the heteroatom is selected from S, N, O, P, B or Si;
h on any C in the general formula I can be independently substituted by halogen.
3. The electrolyte of claim 2, wherein: the substituent R is selected from H, halogen atom, carbonyl, ester group, aldehyde group, ether oxygen group, ether sulfur group, ═ O, ═ S,
Figure FDA00028092769400000111
Nitro, cyano, amino, amide, sulfonamide, sulfoalkane, hydrazino, diazo, alkyl, heteroalkyl, cyclic substituents, salt substituents, and any of these groups wherein hydrogen H is substituted with a halogen atom; r2And R3Independently is H, hydrocarbyl or a ring;
wherein the ester group includes carboxylic acid esters, carbonic acid esters, sulfonic acid esters, and phosphoric acid esters; hydrocarbyl groups include alkyl, alkenyl, alkynyl, and alkenylalkynyl groups; heterohydrocarbyl is hydrocarbyl containing at least one non-carbon atom, including heteroalkyl, heteroalkenyl, heteroalkynyl, and heteroalkynynyl; the non-carbon atoms are selected from halogen, N, P, S, O, Se, Al, B and Si; the ring substituent comprises a ternary-eight-membered ring and a polycyclic ring formed by at least two monocyclic rings; such salt substituents include, but are not limited to, sulfate, sulfonate, sulfonimide salts, carbonate, thioether, oxoether, nitrogen, hydrochloride, nitrate, azide, silicate, phosphate;
preferably, the carbonyl group is
Figure FDA0002809276940000014
The ester group is-R55COOR56、-R55OCOR54、-R55SO2OR56Or R55O-CO-OR56Or
Figure FDA0002809276940000015
Amino is ═ N-R21
Figure FDA0002809276940000016
or-CH ═ N-R81Amide is
Figure FDA0002809276940000017
Sulfonamide group of
Figure FDA0002809276940000018
Figure FDA0002809276940000019
The sulfoalkane is
Figure FDA00028092769400000110
Diazo is-N ═ N-R16With an ether oxygen radical of-R31OR32The etherthio radical is-R31SR32(ii) a Wherein R is2、R3、R16、R21、R22、R23、R24、R25、R31、R32、R40、R41、R42、R43、R44、R45、R46、R50、R51、R52、R54、R55、R56、R57、R79、R80、R81Independently an alkyl, heteroalkyl, alkenyl, heteroalkenyl, alkynyl, heteroalkynyl, ring, or a group in which H on any one of these groups, C, is substituted with a halogen, a heteroalkane/alkene/alkynyl being an alkane/alkene/alkynyl containing at least one of the non-carbon atoms; and R is2、R3、R16、R21、R23、R25、R40、R41、R42、R79、R80、R81Can also be H, R22、R24、R31、R44、R45、R50、R55Can also be absent; the group directly attached to N or O can also be a metal ion.
4. The electrolyte of claim 3, wherein: e1、E2Or E3Selected from the group consisting of a carbonyl group, a carbonyl-containing group, an ester-containing group, an alkyl group, a heteroalkyl group, an alkenyl group, a heteroalkenyl group, an alkynyl group, a group containing a cyclic structure, a substituted aryl group, a substituted heteroaryl,
Figure FDA0002809276940000021
Or ═ N-R6-, said heteroalkenyl group includes a structure containing a carbon-carbon double bond C ═ C and a structure containing a carbon-carbon double bond C ═ N, R4、R5And R6Independently of R in claim 32、R3The species defined in (1) are identical;
E4is a chain structure without or containing 3 free connecting bonds and at least one atom, the 3 free connecting bonds are respectively connected with a saturated heterocyclic ring and E1And E2And (4) connecting.
5. The electrolyte of claim 4, wherein: in the general formula I, the saturated heterocycle is a three-membered ring, a four-membered ring, a five-membered ring, a six-membered ring, a seven-membered ring, an eight-membered ring, a nine-membered ring, a ten-membered ring, a twelve-membered ring, a fourteen-membered ring, a sixteen-membered ring and an eighteen-membered ring; preferably, the saturated heterocyclic ring is a three-membered ring, a four-membered ring, a five-membered ring, a six-membered ring, a seven-membered ring, an eight-membered ring, a sixteen-membered ring and an eighteen-membered ring;
preferably, the three-membered ring: contains a heteroatom; a four-membered ring: containing 1 or 2 heteroatoms; five-membered ring: containing 1,2, 3 or 4 heteroatoms; a six-membered ring: containing 1,2, 3, 4, 5 or 6 heteroatoms; seven-, eight-, nine-membered rings: containing 1,2, 3 or 4 heteroatoms; ten-, twelve-, fourteen-membered rings: containing 1,2, 3, 4 or 5 heteroatoms; sixteen and eighteen membered rings: containing 1,2, 3, 4, 5 or 6 heteroatoms;
any one of the heteroatoms in each saturated heterocycle is independently selected from S, N, O, P, Se, B, or Si.
6. The electrolyte of claim 5, wherein: in formula I, the saturated heterocycle is selected from: a three-membered heterocyclic ring containing 1O, 1N or 1S, a four-membered heterocyclic ring containing 1O, 1S, 1N, 2O, 2N or 1N and 1O at the same time, a five-to eight-membered heterocyclic ring containing 1S, 1N, 1O, 1 Si, 1P, 2S, 2N, 2O, 3O, 1O and 1S at the same time, 1O and 1N at the same time, 1N and 1S at the same time, 1 Si and 1N at the same time, 1O and 1P at the same time, 1N and 1P at the same time, 2N and 1P at the same time, 3N and 3P at the same time, 2O and 1P at the same time, or 2O and 1 Si at the same time; a ten-to sixteen-membered heterocycle containing 1O, 1S, 1N, 3N, 4O, 4S, 4N, 5O or 5S, or an eighteen-membered heterocycle containing 5O, 5S, 6O, 6S or both 5O and 1N, in each of which there are two-OBFs3M is directly or indirectly attached to any one or two heterocyclic ring atoms;
more preferably, the saturated heterocyclic ring includes, but is not limited to:
Figure FDA0002809276940000022
Figure FDA0002809276940000023
h on any one C in the saturated heterocyclic ring can be independently substituted by the substituent R.
7. The electrolyte of claim 6, wherein: the general formula I includes, but is not limited to, the following compounds:
Figure FDA0002809276940000024
Figure FDA0002809276940000031
in the above structure, Q1、Q2、Q3All indicate-OBF3M; e in each ring structure1、E2、E3And E4Independently of each other, as defined in any one of claims 1 to 4; any one H on each saturated heterocycle may be independently selected from A1Or A2Any one substituent of (A), A1、A2Are each independently selected from any one of the substituents defined in said substituent R in any one of claims 1-4.
8. The electrolyte of claim 7, wherein: in the substituent A1、A2Or in R, the halogen atoms comprise F, Cl, Br and I;
R2、R3independently H, methyl or ethyl; r21、R22、R23、R24、R25、R31、R32、R40、R41、R42、R43、R44、R45、R46、R50、R51、R52、R54、R55、R56、R57、R79、R80、R81Independently an alkyl group containing 1-20 atoms, a heteroalkyl group containing 1-15 atoms, an alkenyl group containing 1-20 atoms, a heteroalkenyl group containing 1-15 atoms, or a CN containing group, and R22、R24、R31、R44、R45、R50、R55Can also be absent, R21、R23、R25、R40、R41、R42、R79、R80、R81Can also be H, R22、R24、R31、R44、R45、R50、R55Can also be absent; the group directly attached to N or O can also be a metal ion; wherein the ester group can also be selected from-OCH2COOEt or-CH2(CH2)6COOEt; the amide can also be selected from
Figure FDA0002809276940000032
R46Can also be N (CH)2CH2CH2CH3)2;R21Can also be NO22-methylphenyl, 2, 4-dimethylphenyl, 2-methyl-3-chloro-phenyl, 3-trifluoromethylphenyl, CH2COOCH3Cyclohexane, 1, 3-cyclohexadiene, thiazole,
Figure FDA0002809276940000033
Or a fluorotolyl group; r35Can also be selected from the group consisting of octyl, decyl, octadecyl, and-O- (CH)2)2CH(CH3)2(ii) a The carbonyl group can also be selected from the group consisting of-CO-CH (CH)3)CH2CH(CH3)CH2CH3or-CO-CH (CH)3)CH2CH(CH3)CCl2CH2Cl;
Diazo is-N ═ N-R16,R16Is phenyl or phenyl with methyl, halogen atom or nitro connected;
cyano radicals selected from-CN, -CH2CN、-SCH2CH2CN、-N(CH3)CH2CH2CN or-CH2CH2CN;
The alkyl group includes methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, n-pentyl, isopentyl, sec-pentyl, neopentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl; heteroalkyl is an alkyl group containing at least one of the heteroatoms;
the alkenyl group includes vinyl, 1-propenyl, butenyl, pentenyl, hexenyl, heptenyl, octenyl, nonenyl, decenyl, undecenyl, dodecenyl, tridecenyl, tetradecenyl, pentadecenyl, hexadecenyl, heptadecenyl, octadecenyl; heteroalkenyl is alkenyl containing at least one of the heteroatoms;
alkynyl includes ethynyl, propynyl, butynyl, pentynyl, hexynyl, heptynyl; heteroalkynyl is an alkynyl group containing at least one of the heteroatoms;
the alkenylalkynyl group is a structure containing at least one double bond and at least one triple bond; said heteroalkynyl is an alkynyl containing at least one of said heteroatoms;
the ring substituents include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, and polycyclic;
preferably, any one of the H-bearing atoms on any one of the rings of the above-mentioned ring substituents is independently linked to a first substituent of the same type as defined for substituent R; more preferably, the first substituent is selected from the group consisting of H, halogen atom, methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, n-pentyl, isopentyl, sec-pentyl, neopentyl, fluoromethyl, fluoroethyl, methoxy, ethoxy, nitro, alkenyl, alkynyl, ester, sulfonate, sulfoalkane, amide, cyano, aldehyde, -SCH3、-COOCH3、COOCH2CH3、-OCF3、=O、-CO-N(CH3)2
Figure FDA0002809276940000041
Figure FDA0002809276940000042
Or a substituent in which H on any one C of these groups is substituted with halogen; r10Selected from methyl, ethyl or propyl;
any atom with H in any ring structure of the ring substituents of the ring may be independently linked to the saturated heterocycle via the following linking groups: single bond, methyl, ethyl, propyl, butyl, ethylene, propylene, butylene, acetylene, propyne, -COO-, -COCH2-、COOCH2CH2-、-CH2OCH2-、-CH2OCH2CH2-、-OCH2CH2O-、-OCH2-、-OCH2CH2-、-N=N-、-S-、-S-S-、-O-、-CH=CH-COO-CH2CH2-、-CH2OOC-、-CH=CH-CO-、-CH2N(CH3)CH2-、
Figure FDA0002809276940000043
Connecting; r14Selected from H, methyl, ethyl or propyl, R83Selected from alkyl or cyclic.
9. The electrolyte of claim 7, wherein: e1、E2And E3Independently selected from the group consisting of none, carbonyl, keto, ester, -CH2-, ethyl, N-propyl, isopropyl, N-butyl, isobutyl, N-pentyl, isopentyl, sec-pentyl, neopentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, ethenyl, propenyl, butenyl, pentenyl, ethynyl, propynyl, butynyl, pentynyl, hexynyl, heptynyl, octenyl, nonenyl, decenyl, cyclohexyl, cyclopentyl, 1, 3-hexadienyl, -C ═ N-, -C (CH)3)2-、-CH(CH3)-、-CH(CF3)-、-C(CF3)2-、-CH2CH2CH(CH3)-、-Z'1CH2CH2-、-CH2CH(CH3)-、-OCH2-、-CH=CH-CO-、-OCH2CH2CH2CO-、=N-CH2-CO-、-Z'1CH2CO-、-Z'1CH2CH2CO-、-Z'1CH2CH2CH2CO-、-COOCH2CH2-、-CH(CH3)CO-、-CH(CH2Cl)-、-CH(OCH3)-、-CH(CHO)-、-CH2COCO-、-C(CH3)2CH2CH2-、-O-CH2(CH2)4CH2-、-CH2CH2CO-、-CH2(CH2)5CO-、-N=C(CH3)-、-O-(CH2)6-、-CH2Z'1CH2-、-CH2(CH3)Z'1CH2-、-CH2CH2Z'1CH2-、-CH2CH(CH3)Z'1CH2-、
Figure FDA0002809276940000044
Figure FDA0002809276940000045
-O-CH2-CH2-O-CH2-CH2-、
Figure FDA0002809276940000051
-(CH3)CHCH2CH2Z’1CH2-、-O-CH(CH3)-(CH2)4CH2-、
Figure FDA0002809276940000052
Figure FDA0002809276940000053
E4Selected from among,
Figure FDA0002809276940000054
Figure FDA0002809276940000055
Wherein Z 'of claim'1is-O-, -S-S-, -COO-,
Figure FDA0002809276940000056
-CS-, wherein R11Is H, methyl, ethyl, propyl, isopropyl, butyl, ethoxy or methoxy, and the R is11Any one of hydrogen and H in (1) can be replaced by F or Cl; r is59、R60Independently an alkyl group or a ring;
R13、R96independently selected from H, methyl, ethyl, propyl, butyl, pentyl, cyclopropyl, cyclopentyl, cyclohexyl, nitro, hexyl, thiazolyl, pyrrolyl, -CH (CH)3)2、-CH2CH(CH3)2、-CH2CH2NO3、-CH2CH2CH(CH3)2
Figure FDA0002809276940000057
Wherein R is9Is nothing, methylene, -CH (CH)3)-Ph;R8、R12、R17、R18、R35、R85、R94、R95Independently selected from halogen atom, alkyl, fluoroalkyl, methoxyl, nitryl, aldehyde group, ketone group, ester group or-CH2-N(CH3)2Optionally R being attached to thiazolyl, pyrrolyl or phenyl Ph17Any one of them.
10. The electrolyte of claim 1, wherein: m of the formula I comprises Na+、K+、Li+、Mg2+Or Ca2+Preferably Na+、K+Or Li+
Preferably, the general formula i is: a compound of formula i according to any one of claims 1-9 wherein H on any one C is substituted, wholly or partially, with halogen, preferably F.
11. A method for producing the electrolyte according to any one of claims 1 to 10, characterized in that: the method comprises the step of reacting a saturated heterocyclic ternary structure containing three-OH, a boron trifluoride compound and an M source to obtain a product, namely the product containing three-OBF3M is a saturated heterocyclic boron trifluoride salt.
12. Use of the electrolyte of any one of claims 1 to 10 in a secondary battery, wherein: the application is as follows: the general formula I can be used as an electrolyte additive;
preferably, the application further comprises the application in a liquid electrolyte, a gel electrolyte, a mixed solid-liquid electrolyte, a quasi-solid electrolyte, an all-solid electrolyte, which each independently comprise a saturated heterocyclic boron trifluoride containing salt according to any one of claims 1 to 10;
preferably, the use further comprises use as a battery or battery, said battery comprising the saturated heterocyclic based ternary electrolyte of any of claims 1-10 and a positive electrode, a negative electrode, a separator and a packaging casing; the battery comprises any one of a liquid battery, a mixed solid-liquid battery, a semi-solid battery, a gel battery, a quasi-solid battery and an all-solid battery;
the battery pack includes the battery.
CN202011380889.2A 2020-11-30 2020-11-30 Ternary electrolyte containing saturated heterocycles, and preparation and application thereof Withdrawn CN114573617A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011380889.2A CN114573617A (en) 2020-11-30 2020-11-30 Ternary electrolyte containing saturated heterocycles, and preparation and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011380889.2A CN114573617A (en) 2020-11-30 2020-11-30 Ternary electrolyte containing saturated heterocycles, and preparation and application thereof

Publications (1)

Publication Number Publication Date
CN114573617A true CN114573617A (en) 2022-06-03

Family

ID=81768908

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011380889.2A Withdrawn CN114573617A (en) 2020-11-30 2020-11-30 Ternary electrolyte containing saturated heterocycles, and preparation and application thereof

Country Status (1)

Country Link
CN (1) CN114573617A (en)

Similar Documents

Publication Publication Date Title
CN114644644B (en) Electrolyte containing nitrogen-based salt structure, and preparation method and application thereof
CN114649581B (en) Electrolyte containing five-membered cyclic nitrogen-based salt structure, and preparation method and application thereof
CN114649571A (en) Ternary sulfenyl boron trifluoride salt electrolyte and preparation method and application thereof
CN114230584A (en) Electrolyte containing aromatic ring structure and preparation and application thereof
CN114573617A (en) Ternary electrolyte containing saturated heterocycles, and preparation and application thereof
CN114649582A (en) Electrolyte containing six-membered cyclic nitrogen-based salt structure and preparation method and application thereof
CN114573618A (en) Saturated carbon ring ternary electrolyte and preparation and application thereof
CN114621265A (en) Electrolyte containing saturated heterocyclic structure and preparation method and application thereof
CN114583266A (en) Polycyclic ternary electrolyte and preparation method and application thereof
CN114605444A (en) Electrolyte containing polycyclic structure and preparation method and application thereof
CN114605446A (en) Electrolyte containing saturated carbon ring structure and preparation method and application thereof
CN114573612A (en) Ternary unsaturated carbocyclic boron trifluoride salt electrolyte and preparation method and application thereof
CN114573616A (en) Ternary electrolyte containing bicyclic salt and preparation method and application thereof
CN114605445A (en) Electrolyte containing aromatic ring structure and preparation method and application thereof
CN114573610A (en) Ternary electrolyte containing unsaturated heterocycle and preparation method and application thereof
CN114230587A (en) Electrolyte containing saturated heterocycles and preparation and application thereof
CN114583267A (en) Boron trifluoride salt ternary electrolyte and preparation and application thereof
CN114573611A (en) Ternary electrolyte containing aromatic ring structure and preparation and application thereof
CN114605443A (en) Electrolyte containing unsaturated heterocyclic structure and preparation method and application thereof
CN114621263A (en) Electrolyte containing unsaturated carbon ring structure and preparation method and application thereof
CN114230585A (en) Saturated carbon ring electrolyte and preparation and application thereof
CN114649573A (en) Sulfur-based electrolyte containing saturated heterocycles and preparation method and application thereof
CN114230590A (en) Boron trifluoride salt electrolyte containing unsaturated heterocycle and preparation and application thereof
CN114243105A (en) Electrolyte containing bicyclic salt and preparation and application thereof
CN114230589A (en) Boron trifluoride salt electrolyte and preparation and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20220603

WW01 Invention patent application withdrawn after publication